Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term conformal radiation-therapy. Found 9 abstracts

Pahlajani N, Ruth KJ, Buyyounouski MK, Chen DY, Horwitz EM, Hanks GE, Price RA, Pollack A. RADIOTHERAPY DOSES OF 80 GY AND HIGHER ARE ASSOCIATED WITH LOWER MORTALITY IN MEN WITH GLEASON SCORE 8 TO 10 PROSTATE CANCER. International Journal of Radiation Oncology Biology Physics. 2012 Apr;82(5):1949-56.   PMCID: PMC3827957
Xu QY, Chen Y, Grimm J, Fan JJ, An LL, Xue JY, Pahlajani N, LaCouture T. Dosimetric investigation of accelerated partial breast irradiation (APBI) using CyberKnife. Medical Physics. 2012 Nov;39(11):6621-8.   PMCID: not NIH funded
Zaorsky NG, Li TY, Devarajan K, Horwitz EM, Buyyounouski MK. Assessment of the American Joint Committee on Cancer Staging (Sixth and Seventh Editions) for Clinically Localized Prostate Cancer Treated With External Beam Radiotherapy and Comparison With the National Comprehensive Cancer Network Risk-Stratification Method. Cancer. 2012 Nov;118(22):5535-43.   PMCID: PMC3410044
Sharma NK, Li TY, Chen DY, Pollack A, Horwitz EM, Buyyounouski MK. INTENSITY-MODULATED RADIOTHERAPY REDUCES GASTROINTESTINAL TOXICITY IN PATIENTS TREATED WITH ANDROGEN DEPRIVATION THERAPY FOR PROSTATE CANCER. International Journal of Radiation Oncology Biology Physics. 2011 Jun;80(2):437-44.   PMCID: PMC2909627
Buyyounouski MK, Hanlon AL, Eisenberg DF, Horwitz EM, Feigenberg SJ, Uzzo RG, Pollack A. Defining biochemical failure after radiotherapy with and without androgen deprivation for prostate cancer. International Journal of Radiation Oncology Biology Physics. 2005 Dec;63(5):1455-62.
Feigenberg SJ, Hanlon AL, Horwitz EM, Uzzo RG, Eisenberg DF, Pollack A. What pretreatment prostate-specific antigen level warrants long-term androgen deprivation?. International Journal of Radiation Oncology Biology Physics. 2005 Mar 15;61(4):1003-10.
Lattanzi J, McNeeley S, Pinover W, Horwitz E, Das I, Schultheiss TE, Hanks GE. A comparison of daily CT localization to a daily ultrasound- based system in prostate cancer. International Journal of Radiation Oncology Biology Physics. 1999 Mar;43(4):719-25.
Das IJ, Desobry GE, McNeeley SW, Cheng EC, Schultheiss TE. Beam characteristics of a retrofitted double-focused multileaf collimator. Medical Physics. 1998 Sep;25(9):1676-84.
Lattanzi J, McNeely S, Hanlon A, Das I, Schultheiss TE, Hanks GE. Daily CT localization for correcting portal errors in the treatment of prostate cancer. International Journal of Radiation Oncology Biology Physics. 1998 Jul 15;41(5):1079-86.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term conformal radiation-therapy

conformal radiation-therapy prostate cancer carcinoma radiation therapy antigen distant metastases organ motion irradiation prostate-specific antigen locally advanced-carcinoma radical prostatectomy neoadjuvant intensity-modulated radiotherapy external-beam radiotherapy dose-escalation follow-up radiotherapy phase-iii trial gleason score suppression randomized controlled-trial beam staging prostate cancer-radiotherapy-American Joint Committee on Cancer-National Comprehensive Cancer Network Androgen computed tomography definitive radiotherapy double-focused leaves High grade iii randomized trial men androgen deprivation therapy radiology CyberKnife APBI-planning progression american society randomized trial complications intensity modulation Gastrointestinal toxicity psa velocity deprivation therapy Radiation adjuvant therapy ultrasound consensus motion clinically localized adenocarcinoma escalation trial Intensity-modulated radiotherapy 20-year prostatic neoplasms prognostic-factors group protocol 92-02 multileaf collimator dose-escalation trial Survival competing risk randomized-trial rectum 10-year cancer predict pathological stage bladder three-dimensional conformal radiotherapy leaf quality assurance fusion adjuvant linear-accelerator local recurrences recursive partitioning analysis movement markers conference treatment failure electron contamination mri image morbidity collimators alloy blocks mastectomy Prostate cancer high-energy photon localized dose-response Dose escalation characteristics consensus definition defining biochemical failure androgen conserving surgery
Last updated on Wednesday, February 05, 2020